Lobesity is focused on the clinical and commercial development of breakthrough therapies for obesity. Founded in 2015 by researchers, M. Michael Wolfe, M.D. and Michael O. Boylan, Ph.D., our innovative, proprietary anti-GIP monoclonal antibody targets obesity at its roots.
Street AddressStreet Address Line 2CityState / Province / RegionPostal / Zip CodeE-mail:*Phone:
Dr. Stephen Charles, 11000 Cedar Avenue, Cleveland, OH 44106-3052